Alivus Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
1,091.40
43.4 (4.14%)
BSENSE

May 26

BSE+NSE Vol: 1.32 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Alivus Life
Caplin Point Lab
Viyash Scientifi
Strides Pharma
Corona Remedies
Sanofi Consumer
Jubilant Pharmo
Alembic Pharma
Concord Biotech
Cohance Life
Rubicon Research

Why is Alivus Life Sciences Ltd ?

1
High Management Efficiency with a high ROE of 19.43%
2
The company is Net-Debt Free
3
With ROE of 17.5, it has a Fair valuation with a 3.9 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -1.14%, its profits have risen by 20.2% ; the PEG ratio of the company is 1.1
4
Majority shareholders : Promoters
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Alivus Life should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Alivus Life for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Alivus Life
-1.07%
-0.04
26.65%
Sensex
-7.47%
-0.55
13.00%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
6.24%
EBIT Growth (5y)
5.36%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.92
Tax Ratio
24.87%
Dividend Payout Ratio
12.62%
Pledged Shares
0
Institutional Holding
12.57%
ROCE (avg)
31.22%
ROE (avg)
19.43%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
22
Industry P/E
34
Price to Book Value
3.88
EV to EBIT
16.91
EV to EBITDA
15.32
EV to Capital Employed
4.68
EV to Sales
4.79
PEG Ratio
1.11
Dividend Yield
0.47%
ROCE (Latest)
27.70%
ROE (Latest)
17.52%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
PAT(9M)

At Rs 462.38 cr has Grown at 23.58%

NET SALES(Q)

Highest at Rs 689.12 cr

EPS(Q)

Highest at Rs 13.25

-2What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 2.13 cr

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.38 times

Loading Valuation Snapshot...

Here's what is working for Alivus Life

Profit After Tax (PAT) - Nine Monthly
At Rs 462.38 cr has Grown at 23.58%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 689.12 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 13.25
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Alivus Life

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 2.13 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Lowest at 2.38 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly
Highest at Rs 22.78 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income